COVID-19: A Centennial Pandemic from Origin to Clinical Trials

Author:

Vidwans Ruddhida R1,Lankadasari Manendra Babu2

Affiliation:

1. PhD Research Scholar, Department of Microbiology , Jain University , Bangalore , India

2. Independent Researcher, Dr. No: 6/30, PedhaVeedi, Gudiwada, Andhra Pradesh , India

Abstract

Abstract In December 2019, an unexpected interaction of coronavirus with human’s occurred for the third time in history after Severe Acute Respiratory Syndrome (SARS) in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012. Soon the virus was confirmed as SARS-CoV-2, and the severity of its transmission lead the World Health Organization to declare it as World Pandemic. Due to its highly contagious nature, new methods like social distancing, self-hygiene and quarantine were being adopted by many countries to halt the transmission. Due to the dearth in specific therapeutics and/or vaccines against Coronavirus Disease (COVID-19), a significant thrust in drugs and vaccine discovery was ratified by all the nations. The current review comprehensively details about the emergence and molecular pathogenesis with an interesting timeline which notes all the major events during this crisis. Given the potential general readers and health workers, the symptoms and diagnostic approaches were simplified. Emphasis was given to therapeutic approaches and clinical trials section to support the translational research and to cope up with the viral outbreak.

Publisher

Walter de Gruyter GmbH

Reference78 articles.

1. 1. Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, Makhawi AM (2020) Design of multi epitope-based peptide vaccine against E protein of human 2019-nCoV: An immunoinformatics approach. BioRxiv 2020.02.04.934232. doi: 10.1101/2020.02.04.934232

2. 2. Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR (2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio 9:e00221-18. doi: 10.1128/mBio.00221-18

3. 3. Albarello F, Pianura E, Di SF, Cristofaro M, Petrone A, Marchioni L, Palazzolo C, Schininà V, Nicastri E, Petrosillo N, Campioni P, Eskild P, Zumla A, Ippolito G, Abbonizio MA, Agrati C, Amadei G, Amendola A, Antonini M, Barbaro R, Bartolini B, Benigni M, Bevilacqua N, Bordi L, Bordoni V, Branca M, Capobianchi MR, Caporale C, Caravella I, Carletti F, Castilletti C, Chiappini R, Ciaralli C, Colavita F, Corpolongo A, Curiale S, D’Abramo A, Dantimi C, Angelis AD, Angelis GD, Lorenzo RD, Stefano FD, Ferraro F, Fiorentini L, Frustaci A, Gallì P, Garotto G, Giancola ML, Giansante F, Giombini E, Greci MC, Lalle E, Lanini S, Lapa D, Lepore L, Lucia A, Lufrani F, Macchione M, Marani A, Mariano A, Marini MC, Maritti M, Matusali G, Meschi S, Montaldo FMC, Murachelli S, Noto R, Pallini E, Passeri V, Pelliccioni F, Petrecchia A, Pisciotta M, Pittalis S, Proietti C, Puro V, Rinonapoli G, Rueca M, Sacchi A, Sanasi F, Santagata C, Scarcia S, Scognamiglio P, Scorzolini L, Stazi G, Vaia F, Vairo F, Valli MB (2020) 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. Int J Infect Dis 93:192–197. doi: 10.1016/j.ijid.2020.02.043.

4. 4. Alraddadi BM, Watson JT, Almarashi A, Abedi GR, Turkistani A, Sadran M, Housa A, Almazro MA, Alraihan N, Banjar A, Albalawi E, Alhindi H, Choudhry AJ, Meiman JG, Paczkowski M, Curns A, Mounts A, Feikin DR, Marano N, Swerdlow DL, Gerber SI, Hajjeh R, Madani TA (2016) Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis 22:49–55. doi: 10.3201/eid2201.151340

5. 5. Aylward, Bruce (WHO), Liang W (PRC) (2020) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). In- The WHO-China Joint Mission on Coronavirus Disease 2019, 2019(February):16–24. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed 05 April 2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3